Form 4: Merus N.V. Executive Peter Silverman Awarded Stock Options

Merus N.V. Chief Operating Officer and General Counsel, Peter Silverman, was granted 125,000 stock options on January 29, 2025.

Summary

• Peter Silverman, the Chief Operating Officer and General Counsel of Merus N.V., was granted 125,000 stock options.
• The options have an exercise price of $41.65 per share.
• The options vest over a four-year period starting January 1, 2025, with 25% vesting on January 1, 2026, and the remaining vesting in 36 equal monthly installments thereafter.
• The options expire on January 29, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.

Positives

• The granting of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with the long-term success of the company.

Comparison to Industry Standards

• Stock option grants are a standard practice for incentivizing executives in the biotech industry.
• The vesting schedule of four years with a cliff vest at one year followed by monthly vesting is a common structure.
• The exercise price is typically set at or above the market price at the time of grant.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes management to increase shareholder value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, executive compensation, insider trading, Merus N.V., MRUS, Peter Silverman, COO, General Counsel